Urinary 7a-hydroxy-3-oxochol-4-en-24-oic and 3-oxochola-4,6-dien-24-oic acids in infants with cholestasis

Journal of Hepatology

Volumn 28, Issue 2, 1998, Pages 270-279

  Kimura, Akihiko ^a   Suzuki, Mikako ^b   Murai, Tsuyoshi ^b   Kurosawa, Takao ^b   Tohma, Masahiko ^b   Sata, Michio ^a   Inoue, Toshiro ^a   Hoshiyama, Atsuo ^a   Nakashima, Eisuke ^a   Yamashita, Yasuhiro ^a   Fujisawa, Takuji ^a   Kato, Hirohisa ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

3 oxo 4 steroid 5 reductase; Cholestasis; Infant; Ketonic bile acid

Indexed keywords

BILE ACID; STEROID REDUCTASE; 3 OXO 7 HYDROXYCHOL 4 ENOIC ACID; 3-OXO-5 BETA-STEROID DELTA 4-DEHYDROGENASE; 3-OXO-7-HYDROXYCHOL-4-ENOIC ACID; CHENODEOXYCHOLIC ACID; DRUG DERIVATIVE; OXIDOREDUCTASE; STEROID 5BETA REDUCTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHOLESTASIS; ENZYME DEFICIENCY; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INFANT; LIVER DISEASE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROGNOSIS; BILE DUCT ATRESIA; CASE CONTROL STUDY; MASS FRAGMENTOGRAPHY; MIDDLE AGED; PRESCHOOL CHILD; URINE;

ADOLESCENT; ADULT; AGED; BILIARY ATRESIA; CASE-CONTROL STUDIES; CHENODEOXYCHOLIC ACID; CHILD; CHILD, PRESCHOOL; CHOLESTASIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; INFANT; LIVER DISEASES; MALE; MIDDLE AGED; OXIDOREDUCTASES;

EID: 0032006594     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8278(88)80014-X     Document Type: Article

References (38)

1. 403-Oxosteroid 5β-reductase deficiency described in identical twins with neonatal hepatitis: a new inborn error in bile acid synthesis. J Clin Invest. 82:1988;2148-2157.
2. Balistreri WF. Fetal and neonatal bile acid synthesis and metabolism - clinical implications. J Inher Metab Dis. 14:1991;459-477.
3. 4-3-oxosteroid 5β-reductase deficiency). Hepatology. 18:1993;1096-1101.
4. 4-3-Oxosteroid 5β-reductase deficiency causing neonatal liver failure and hemochromatosis. J Pediatr. 124:1994;234-238.
5. Balistreri WF. Inborn errors of bile acid biosynthesis: clinical and therapeutic aspects. Hofmann AF, Paumgartner G, Stiehl A. Bile Acids in Gastroenterology, Basic and Clinical Advances. 1995;333-353 Kluwer Academic Publishers, Dordrecht, Boston, London.
6. 4 bile acids in liver disease. Lancet. i:1988;1283-1284.
7. Clayton PT. Inborn errors of bile acid metabolism. J Inher Metab Dis. 14:1991;478-496.
8. 4-3-Oxosteroid 5β-reductase deficiency and neonatal hemochromatosis. J Pediatr. 125:1994;845-846.
9. Kimura A, Ushijima K, Suzuki M, Tohma M, Inokuchi T, Kato H. Profile of urinary bile acids in familial intrahepatic cholestasis with Coombs' negative haemolytic anaemia. Acta Paediatr. 84:1995;1119-1124.
10. Nakagawa M, Setchell KDR. Bile acid metabolism in early life: studies of amniotic fluid. J Lipid Res. 31:1990;1089-1098.
11. Wahlén E, Egested B, Strandvik B, Sjövall J. Ketonic bile acids in urine of infants during the neonatal period. J Lipid Res. 30:1989;1847-1857.
12. 4-3-ketosteroid 5β-reductase and a 3α-hydroxysteroid dehydrogenase. Eur J Biochem. 2:1967;493-502.
13. 4-3-ketosteroid 5β-reductase. J Biol Chem. 259:1984;7519-7524.
14. 4-3-ketosteroid 5β-reductase of rat liver. FEBS Lett. 283:1991;215-218.
15. 4-3-Oxosteroid 5β-reductase, structure and function. Biol Chem Hoppe-Seyler. 372:1991;1039-1049.
16. Russell DW, Setchell KDR. Bile acid biosynthesis. Biochemistry. 20:1992;4737-4749.
17. 4-3-oxosteroid 5β-reductase and substrate specificity of the expressed enzyme. Eur J Biochem. 219:1994;357-363.
18. Stieger B, Zhang J, O'Neill B, Sjövall J, Meier PJ. Transport of taurine conjugates of 7α-hydroxy-3-oxo-4-cholenoic acid and 3b,7α-dihydroxy-5-cholenoic acid in rat liver plasma membrane vesicles. van Berge Henegouwen GP, van Hoek B, De Groote J, Matern S, Stockbrügger RW. Cholestatic Liver Disease: New Strategies for Prevention and Treatment of Hepatobiliary and Cholestatic Liver Disease Dordrecht. 1994;82-87 Kluwer Academic Publishers, Boston, London.
19. Setchell KDR. Disorders of bile acid synthesis. Walker WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB. Pediatric Gastrointestinal Disease, Pathophysiology, Diagnosis, Management. 2:1991;992-1013 B.C. Deker Inc. Philadelphia, Toronto.
20. Tohma M, Mahara R, Takeshita H, Kurosawa T, Ikegawa S. Synthesis of the 1β-hydroxylated bile acids, unusual bile acids in human biological fluids. Chem Pharm Bull (Tokyo). 34:1986;2890-2899.
21. Tohma M, Mahara R, Takeshita H, Kurosawa T. A convenient synthesis of 3β,12α-, 3β,7α-, and 3β,7β-dihydroxy-5-cholen-24-oic acids: unusual bile acids in human biological fluids. Steroid. 48:1986;331-338.
22. Kurosawa T, Mahara R, Nittono H, Tohma M. Synthesis of 6-hydroxylated bile acids and identification of 3α,6α,7α,12α-tetrahydroxy-5β-cholan-24-oic acid in human meconium and neonatal urine. Chem Pharm Bull (Tokyo). 37:1989;557-559.
23. Mahara R, Kurosawa T, Tohma M. Profile analysis of bile acids in human fetal and neonatal periods by gas chromatography mass-spectrometry (in Japanese). Proc Jap Soc Biomed Mass Spectrum. 14:1989;67-74.
24. Yoshimura T, Mahara R, Kurosawa T, Ikegawa S, Tohma M. An efficient synthesis of 4β- and 6α-hydroxylated bile acids. Steroids. 58:1993;52-58.
25. Leppik RA. Improved synthesis of 3-keto, 4-ene-3-keto, and 4,6-diene-3-keto bile acids. Steroids. 41:1983;475-484.
26. Iida T, Nishida S, Chang FC, Niwa T, Goto J, Nambara T. Potential bile acid metabolism. XXI: a new synthesis of allochenodeoxycholic and allocholic acids. Chem Pharm Bull (Tokyo). 41:1993;763-765.
27. 4,6-bile acids and related compounds in biological fluids of patients with cholestasis by gas chromatography-mass spectrometry. J Chromatogr B. 693:1997;11-21.
28. Suchy FJ, Balistreri WF, Heubi JE, Searcy JE, Levin RS. Physiologic cholestasis: elevation of the primary serum bile acid concentrations in normal infants. Gastroenterology. 80:1981;1037-1041.
29. Balistreri WF, Heubi JE, Suchy FJ. Immaturity of the enterohepatic circulation in early life: factors predisposing to "physiologic" maldigestion and cholestasis. J Pediatr Gastroenterol Nutr. 2:1983;346-354.
30. Javitt N, Emerman S. Effect of sodium taurolithocholate on bile flow and bile acid excretion. J Clin Invest. 47:1968;1002-1014.
31. MacDonald IA, Bokkenheuser VD, Winter J, McLernon AM, Mosbach EH. Degradation of steroid in the human gut. J Lipid Res. 24:1983;675-700.
32. Hylemon PB. Metabolism of bile acids in intestinal microflora. Danielsson H, Sjövall J. Sterols and Bile Acids. 1985;331-343 Elsevier Science Publishers B.V. Amsterdam.
33. Roitmi VD, Doerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol. 14:1981;51-62.
34. Coleman JP, White WB, Egestad B, Sjövall J, Hylemon PB. Biosynthesis of a novel bile acid nucleotide and mechanism of 7α-dehydroxylation by an intestinal Eubacterium species. J Biol Chem. 262:1987;4701-4707.
35. 4-steroid intermediate. J Lipid Res. 30:1989;1033-1039.
36. Hayakawa S, Samuelsson B. Transformation of cholic acid in vitro by Corynebacterium simplex. J Biol Chem. 239:1964;94-97.
37. 4-3-Oxosteroid 5β-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid. Gut. 38:1996;623-628.
38. 4-steroid 5β-reductase deficiency by use of immunoblot analysis. Eur J Pediatr. 156:1997;. in press.